What Does Melatonin Do in Skin Cells?

Two melatonin systems, one molecule

The pineal gland produces melatonin in response to darkness and releases it into the bloodstream. This is the version most people know. It signals to the body that night has arrived, and it coordinates the cascade of physiological changes associated with sleep. The relationship between melatonin and the sleep-wake cycle is real and well-documented.

What is considerably less known is that the pineal gland is not the only place in the body that produces melatonin. The skin makes it independently. Keratinocytes and melanocytes synthesise melatonin locally through the same enzymatic pathway the pineal gland uses, beginning with the amino acid tryptophan. The concentrations produced this way are not negligible. Research by Slominski and colleagues has documented this local synthesis extensively, establishing that the skin's melatonin system is not simply a spillover from pineal output but an autonomous process operating within the tissue itself.1

This distinction matters because it changes how you interpret any study on topical melatonin. The skin already has the molecular architecture to produce, receive, and respond to melatonin. Applying it topically is not introducing a foreign molecule. It is adding to a system the skin already runs.

MT1 and MT2: the receptors that change everything

Skin cells express two dedicated melatonin receptors: MT1 and MT2. These are G protein-coupled receptors found on keratinocytes and other skin cell types, and they have been shown to respond to melatonin concentrations in the range achievable through topical application.1,2

The presence of these receptors is what distinguishes melatonin from a simple antioxidant. When melatonin binds to MT1 or MT2, it triggers intracellular signalling cascades. These cascades influence gene expression, cell cycle regulation, and the upregulation of the skin's own defensive enzyme systems. The molecule is acting as a signal, not just a scavenger. This is qualitatively different from how most antioxidant ingredients work, the majority of which react directly with free radicals and are then consumed, without triggering any downstream change in how the cell manages future oxidative stress.

MT1 and MT2 are not the only pathway. Being a small amphiphilic molecule, melatonin also crosses cell membranes directly without receptor involvement and accesses intracellular compartments including the mitochondria and the nucleus, where additional effects have been documented.

Amphiphilicity: reaching every compartment

Most active ingredients are either water-soluble or fat-soluble. That chemical property determines where in the skin they can travel. Water-soluble compounds move through the aqueous intracellular space but cannot readily cross lipid-rich cell membranes. Fat-soluble compounds cross membranes freely but cannot penetrate the water-based interior of cells. Each type is effectively limited to certain compartments.

Melatonin is genuinely amphiphilic: soluble in both water and lipids. This allows it to move through the hydrophilic intracellular space and to cross the lipophilic cell membrane. Topical application has been shown to result in measurable skin penetration,3 and the molecule's dual solubility means it reaches compartments most actives cannot, including the aqueous cytoplasm, the lipid bilayer, the mitochondrial membrane, and the nucleus.

For an overnight repair formula specifically, mitochondrial access matters. Mitochondria are among the most metabolically active structures in skin cells during the repair window, and they are also the primary intracellular source of reactive oxygen species. An antioxidant that reaches the mitochondria is doing its work where the demand is highest.

The antioxidant cascade

Melatonin reacts directly with free radicals and neutralizes them. But the more significant aspect of its antioxidant activity is what happens after that initial reaction.

When melatonin neutralizes a reactive oxygen species, it is converted to a metabolite called AFMK (N1-acetyl-N2-formyl-5-methoxykynuramine). AFMK is not inert. It is itself an antioxidant with demonstrated radical-scavenging activity. AFMK is in turn metabolized to AMK (N1-acetyl-5-methoxykynuramine), which also has antioxidant properties.4

The result is that melatonin does not simply trade itself for one radical and disappear. The cascade of melatonin and its sequential metabolites collectively neutralizes multiple reactive oxygen species before the chain ends. This is structurally different from antioxidants like vitamin C or vitamin E, which react stoichiometrically with one radical per molecule and are then consumed. A single melatonin molecule initiates a process that continues beyond itself.

Upregulating the skin's own defences

The receptor-mediated signalling pathway is, arguably, the most significant aspect of melatonin's action in skin cells. This is where it moves from being a sophisticated antioxidant to being something more accurately described as a repair signal.

Melatonin upregulates the gene expression of three key antioxidant enzymes in skin: superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). These are enzymes the skin produces as part of its normal biology to manage oxidative stress. A controlled study in ex vivo human skin demonstrated that melatonin enhanced the expression of these three enzymes, prevented their depletion by UV radiation, and reduced the formation of oxidative DNA damage markers.5

The practical implication of this is substantial. Applying melatonin does not just add an antioxidant to the surface of the skin. It increases the skin's own production of antioxidant machinery. After the applied melatonin itself has been metabolized, the cellular systems it upregulated remain active. The skin has been made, for a period, better equipped to manage its own oxidative burden.

This also explains why the effects of melatonin in skin cannot be modeled as simply proportional to concentration the way a pure stoichiometric antioxidant might be. The gene expression effects operate through receptor binding and intracellular signalling. The dose-response relationship is more complex, and the downstream effects outlast the molecule itself.

What the topical research shows

Several controlled studies have examined the effects of topically applied melatonin on human skin, using concentrations comparable to those found in cosmetic products.

A 1998 human in vivo study applied melatonin in combination with vitamins E and C and found measurable protection against UV-induced erythema compared to placebo.6 The combined formulation outperformed either vitamin alone in the conditions tested, which is consistent with the idea that melatonin's receptor-mediated mechanism is additive to rather than duplicative of conventional direct antioxidant activity.

The most comprehensive review of melatonin in a skin aging context, by Kleszczynski and Fischer, synthesised the evidence across multiple mechanisms: oxidative stress, UV damage, mitochondrial function, and inflammatory pathways involved in skin aging.2 It remains the reference most commonly cited in dermatological and cosmetic science literature when discussing topical melatonin. It also makes clear that the evidence base, while growing, is not yet at the level of long-term clinical trials. Acknowledging that is part of reading the literature accurately.

What reduces the skin's melatonin signal

Two factors are most directly relevant to how much melatonin the skin has available during its overnight repair window.

Age. Pineal melatonin production declines measurably with age. Evidence suggests the skin's own synthesis capacity decreases over time as well. The older the skin, the less melatonin it has available from both systemic and local sources to run the repair signalling that depends on it. This is one of the mechanisms thought to contribute to the reduced repair efficiency observed in aging skin.

Artificial light at night. Blue-spectrum artificial light suppresses pineal melatonin production. The research on this is among the most replicated findings in chronobiology.7 The skin's local synthesis is partially independent of pineal output, but the systemic melatonin signal that would otherwise reinforce the local system is reduced. The person using screens until midnight in a brightly lit room is working against the biology that skin repair depends on, whether or not they apply any skincare product afterward.

Neither of these factors is unusual. Most people over thirty, using devices in the evening, are affected by both simultaneously. Understanding what melatonin does in skin cells makes the practical relevance of this clearer.